IL158171A0 - Compositions and methods for cell separation - Google Patents

Compositions and methods for cell separation

Info

Publication number
IL158171A0
IL158171A0 IL15817102A IL15817102A IL158171A0 IL 158171 A0 IL158171 A0 IL 158171A0 IL 15817102 A IL15817102 A IL 15817102A IL 15817102 A IL15817102 A IL 15817102A IL 158171 A0 IL158171 A0 IL 158171A0
Authority
IL
Israel
Prior art keywords
methods
cell separation
compositions
reagents
high yield
Prior art date
Application number
IL15817102A
Other languages
English (en)
Original Assignee
Bioergonomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioergonomics Inc filed Critical Bioergonomics Inc
Publication of IL158171A0 publication Critical patent/IL158171A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/539—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
    • G01N33/541—Double or second antibody, i.e. precipitating antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Ecology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cell Separators (AREA)
  • Processing Of Solid Wastes (AREA)
IL15817102A 2001-04-10 2002-03-07 Compositions and methods for cell separation IL158171A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28282301P 2001-04-10 2001-04-10
PCT/US2002/007079 WO2002083262A1 (fr) 2001-04-10 2002-03-07 Compositions et methodes de separation cellulaire

Publications (1)

Publication Number Publication Date
IL158171A0 true IL158171A0 (en) 2004-03-28

Family

ID=23083276

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15817102A IL158171A0 (en) 2001-04-10 2002-03-07 Compositions and methods for cell separation
IL158171A IL158171A (en) 2001-04-10 2003-09-30 Compositions, kits and methods for cell separation

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL158171A IL158171A (en) 2001-04-10 2003-09-30 Compositions, kits and methods for cell separation

Country Status (12)

Country Link
US (2) US7160723B2 (fr)
EP (2) EP1916297B1 (fr)
JP (2) JP4212898B2 (fr)
CN (1) CN1327927C (fr)
AT (1) ATE493186T1 (fr)
AU (1) AU2002255678B2 (fr)
CA (1) CA2442577C (fr)
DE (1) DE60238801D1 (fr)
IL (2) IL158171A0 (fr)
MX (1) MXPA03009258A (fr)
RU (1) RU2292555C2 (fr)
WO (1) WO2002083262A1 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040242520A1 (en) * 1997-09-06 2004-12-02 Mayo Foundation For Medical Education And Research, A Minnesota Corporation Expression of immonogenic substances
ATE493186T1 (de) 2001-04-10 2011-01-15 Bioe Llc Zelltrennungszusammensetzungen und -verfahren
US7316932B2 (en) * 2001-10-01 2008-01-08 Stemcell Technologies Inc. Method for separating cells
ATE366801T1 (de) * 2002-09-27 2007-08-15 Bioe Inc Zusammensetzungen und verfahren zur trennung von zellen
ATE510005T1 (de) 2003-06-27 2011-06-15 Univ Laval Verfahren zur isolierung von zellen aus der nabelschnur
US7622108B2 (en) 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
WO2005108559A2 (fr) * 2004-04-23 2005-11-17 Bioe, Inc. Cellules précurseurs de plusieurs lignages
CA2646491A1 (fr) * 2006-04-17 2007-10-25 Bioe, Inc. Differenciation des cellules progenitrices a lignees multiples et cellules epitheliales respiratoires
US7598089B2 (en) * 2006-04-19 2009-10-06 Bioe, Inc. Methods and compositions for separating cells
EP2527458A3 (fr) * 2006-05-02 2012-12-26 Therakos, Inc. Methodes et reactifs pour determiner une predisposition a une maladie greffon hote
US7713688B2 (en) 2007-01-26 2010-05-11 Bioe, Llc Methods and compositions for depleting specific cell populations from blood tissues
US20100081121A1 (en) * 2007-02-08 2010-04-01 Ge Healthcare Bio-Sciences Ab Media and method for cell separation
WO2008153802A1 (fr) * 2007-05-29 2008-12-18 Eusa Pharma, Inc. Traitement ex-vivo du cancer au moyen de psma et d'anticorps de psma
JP5210551B2 (ja) * 2007-06-19 2013-06-12 ベックマン コールター バイオメディカル リミテッド 赤血球標識用磁性粒子
EP2192908A4 (fr) * 2007-07-25 2010-09-01 Bioe Inc Différenciation de cellules de progéniteur à multiples lignées en chondrocytes
WO2009041037A1 (fr) * 2007-09-26 2009-04-02 Japan As Represented By The President Of National Cardiovascular Center Médicament pour supprimer un pathogène se produisant in vivo
CA2724839A1 (fr) * 2008-05-21 2009-11-26 Bioe Llc Differenciation de cellules progenitrices de multiples lignees en cellules pancreatiques
US20110195437A1 (en) * 2008-08-04 2011-08-11 Synmed Research Gmbh Method for characterizing, in particular for quantifying, molecular markers that are intracellularly absorbed from tissues by blood macrophages that are recirculated from the tissues into the circulatory system
CN101885770B (zh) * 2009-05-12 2014-07-30 成都生物制品研究所有限责任公司 一种特异性结合cd15的全人源抗体及应用
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
WO2012021512A2 (fr) * 2010-08-10 2012-02-16 Ecole Polytechnique Federale De Lausanne Agents thérapeutiques se liant aux érythrocytes
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US20130288227A1 (en) * 2010-11-01 2013-10-31 Daniel P. Collins Methods and compositions for cell separation of blood tissues
AU2011343735A1 (en) 2010-12-15 2013-07-18 Cytosed, Inc. Antibody-linked immuno-sedimentation agent and method of isolating a target from a sample using same
CN102839152A (zh) * 2011-06-20 2012-12-26 中国科学院上海生命科学研究院 一种快速高效获得抗原特异性b细胞的方法
ES2602500T3 (es) 2011-11-25 2017-02-21 Miltenyi Biotec Gmbh Método de separación celular
WO2015109389A1 (fr) * 2014-01-21 2015-07-30 Stemcell Technologies Inc. Procédé pour séparer des entités cibles d'un échantillon, à l'aide d'une composition de complexes d'anticorps tétramères mono-spécifiques couplés à une surface
KR102717969B1 (ko) 2014-02-21 2024-10-15 에꼴 뽈리떼끄닉 뻬데랄 드 로잔느 (으뻬에프엘) 글리코타겟팅 치료제
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
EP2985289A1 (fr) * 2014-08-14 2016-02-17 Miltenyi Biotec GmbH Déplétion des cellules de souris pour isolation générique de cellules humaines lors d'une xénotransplantation
EP3037170A1 (fr) 2014-12-27 2016-06-29 Miltenyi Biotec GmbH Procédé de séparation de cellules multitris
US10456423B2 (en) 2016-06-13 2019-10-29 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US10426796B2 (en) 2016-06-13 2019-10-01 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US11253579B2 (en) 2017-06-16 2022-02-22 The University Of Chicago Compositions and methods for inducing immune tolerance
EA202092723A1 (ru) 2018-05-09 2021-04-09 Зе Юниверсити Оф Чикаго Композиции и способы, касающиеся иммунной толерантности
CN111235104A (zh) * 2020-03-30 2020-06-05 山东省立医院 一种孕妇外周血胎儿有核红细胞分离纯化方法及分离仪

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US6048715A (en) 1988-07-08 2000-04-11 Univ. Of British Columbia Two-phase partition affinity separation system and affinity separated cell-containing composition
US5397479A (en) * 1993-04-26 1995-03-14 International Remote Imaging Systems, Inc. Composition and method for enrichment of white blood cells from whole human blood
US5514340A (en) * 1994-01-24 1996-05-07 Magnetix Biotechnology, Inc. Device for separating magnetically labelled cells
US5840502A (en) * 1994-08-31 1998-11-24 Activated Cell Therapy, Inc. Methods for enriching specific cell-types by density gradient centrifugation
US6117985A (en) * 1995-06-16 2000-09-12 Stemcell Technologies Inc. Antibody compositions for preparing enriched cell preparations
US5877299A (en) * 1995-06-16 1999-03-02 Stemcell Technologies Inc. Methods for preparing enriched human hematopoietic cell preparations
US6146628A (en) 1995-07-11 2000-11-14 Regents Of The University Of Minnesota And Rutgers Biotherapeutic agents comprising recombinant PAP and PAP mutants
US5773224A (en) * 1996-02-12 1998-06-30 Grandics; Peter Immunoselection system for cell elution
JP4719326B2 (ja) 1996-08-15 2011-07-06 司 松元 赤血球の分画法
AU4101697A (en) * 1996-11-22 1998-05-28 Robert A. Levine Process for enhancing the aggregation and/or agglutination of erythrocytes prior to centrifugation
CA2278208C (fr) * 1997-01-24 2011-09-20 Asahi Medical Co., Ltd. Procede de separation des cellules
ATE329012T1 (de) * 1997-04-08 2006-06-15 Pall Corp Verfahren zur gewinnung von seltenen zellen aus blutprodukten
US6491917B1 (en) * 1998-07-31 2002-12-10 Stemcell Technologies Inc. Antibody composition for debulking blood and bone marrow samples from CML patients
US6153113A (en) * 1999-02-22 2000-11-28 Cobe Laboratories, Inc. Method for using ligands in particle separation
ATE292282T1 (de) 1999-05-28 2005-04-15 Stemcell Technologies Inc Verfahren zur zellseparation unter verwendung von immunorosetten
US7135335B2 (en) 1999-05-28 2006-11-14 Stemcell Technologies Inc. Method for separating cells using immunorosettes
ATE493186T1 (de) 2001-04-10 2011-01-15 Bioe Llc Zelltrennungszusammensetzungen und -verfahren
US7855318B2 (en) 2001-11-13 2010-12-21 U.S. Smokeless Tobacco Company Cloning of cytochrome P450 genes from Nicotiana
ATE366801T1 (de) * 2002-09-27 2007-08-15 Bioe Inc Zusammensetzungen und verfahren zur trennung von zellen
US7713688B2 (en) * 2007-01-26 2010-05-11 Bioe, Llc Methods and compositions for depleting specific cell populations from blood tissues

Also Published As

Publication number Publication date
EP1916297A3 (fr) 2008-05-14
EP1916297A2 (fr) 2008-04-30
CA2442577A1 (fr) 2002-10-24
IL158171A (en) 2012-09-24
JP4212898B2 (ja) 2009-01-21
JP2008289506A (ja) 2008-12-04
JP2004526452A (ja) 2004-09-02
EP1377353A1 (fr) 2004-01-07
US20030027233A1 (en) 2003-02-06
CN1327927C (zh) 2007-07-25
US7160723B2 (en) 2007-01-09
US20070154961A1 (en) 2007-07-05
DE60238801D1 (de) 2011-02-10
CN1658940A (zh) 2005-08-24
MXPA03009258A (es) 2004-11-12
AU2002255678B2 (en) 2008-05-08
US7476547B2 (en) 2009-01-13
RU2003132547A (ru) 2005-03-10
EP1916297B1 (fr) 2010-12-29
WO2002083262A1 (fr) 2002-10-24
RU2292555C2 (ru) 2007-01-27
EP1377353A4 (fr) 2005-08-31
CA2442577C (fr) 2011-08-30
ATE493186T1 (de) 2011-01-15

Similar Documents

Publication Publication Date Title
IL158171A0 (en) Compositions and methods for cell separation
WO2004029208A3 (fr) Compositions et procedes de separation de cellules
WO2004065015A3 (fr) Separateur magnetique
AU2001298049A1 (en) Hla class i and ii binding peptides and their uses
DE69939945D1 (de) Verfahren zur isolierung von stammzellen
WO2005048957A3 (fr) Nouveaux sites d'insertion dans des vecteurs de variole
WO2005047524A3 (fr) Compositions et procedes pour induire la differenciation cellulaire
WO2003020877A3 (fr) Coloration et tri de genomes et de chromosomes au moyen de polyamides specifiques de sequences
AU2002249531A1 (en) Immunotherapy based on dendritic cells
ATE519536T1 (de) Methode zum trennen von zellen
WO2002010337A3 (fr) Methode de clonage de porcs
WO2007127659A3 (fr) Méthodes et compositions pour la séparation de cellules
ATE535256T1 (de) Verfahren und zusammensetzung zur entfernung spezifischer zellpopulationen aus blutgeweben
WO2003000888A3 (fr) Procede de separation de cellules bacteriennes et de composants cellulaires
WO2002064666A3 (fr) Substrats contenant des polyphosphazenes servant de matrice, et substrats contenant des polyphosphazenes presentant une surface microstructuree
WO2004066937A3 (fr) Anticorps specifiques pour les cellules dendritiques plasmacytoides
EP1556404A4 (fr) Antigene p30 genetiquement modifie, combinaison d'antigenes amelioree et utilisations associees
WO2004072262A3 (fr) Cellules presentant l'antigene cd14+ de culture
WO2004005926A3 (fr) Expression d'antigene 5t4
AU2002360791A8 (en) Method of enhancing immunogenicity by covalent linkage of antigens to proteins on the surface of dendritic cells
AU2002257064A1 (en) Methods for isolating proteins expressed by dendritic cells
WO2002018575A3 (fr) Genes exprimes dans le cycle cellulaire
WO2004016803A3 (fr) Procede visant a renforcer les reponses des lymphocytes t cd4+
WO2000077251A3 (fr) Dosages biologiques
AU2002221261A1 (en) Method, antigen and antibody for distinguishing viable and apoptotic cells